The niacin receptor HCAR2 prevents sleep deprivation-induced cognitive impairment by inhibiting microglia-mediated neuroinflammation in mice
International Immunopharmacology · 2025-09 · 162 · 115174
DOI: 10.1016/j.intimp.2025.115174 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-09. Verfasst von Zhaoyan Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu Food & Pharmaceutical Science College, Huai'an, Jiangsu 223003, China. Hauptthemen laut MEDLINE: Sleep Deprivation, Cognitive Dysfunction, Microglia, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Sleep loss has become a common occurrence nowadays, posing significant concerns to public health by increasing risks of various diseases. Studies have shown that sleep loss can cause neuroinflammation and cognitive decline, yet its exact mechanisms and reliable prevention strategies remain unclear. Hydroxycarboxylic acid receptor 2 (HCAR2) is a G protein-coupled receptor expressed in various immune cells, and its activation shows beneficial anti-inflammatory effects in some peripheral and central inflammatory diseases. In this study, we aimed to employ a sleep deprivation (SD) mouse model, combined with genetic and pharmacological manipulation, behavioral tests, biochemical assays and proteomics analysis, to investigate whether activation of HCAR2 could improve SD-induced neuroinflammation and cognitive impairment in mice. We observed that SD significantly disrupted HCAR2 signaling, activated NF-κB/NLRP3 signaling pathway, promoted microglial M1 polarization and ensuing neuroinflammation, impaired synaptic plasticity in the hippocampus of mice, and thereby resulted in cognitive deficits. However, activating HCAR2 with niacin effectively reversed these changes and ultimately alleviated SD-induced cognitive impairment in mice. Our findings suggest that the impaired HCAR2 signaling may be one of the pathogenesis mechanisms of SD, and HCAR2 may represent a promising therapeutic target for sleep loss-related cognitive disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Jiangsu Food & Pharmaceutical Science College, Huai'an, Jiangsu 223003, China.
- Department of Neurosurgery, First Hospital of Jintan District of Changzhou, Changzhou, Jiangsu 213299, China.
- College of Life Science, Northeast Forestry University, Harbin, Heilongjiang 150040, China.
- Department of Scientific Research Office, Jiangsu Food & Pharmaceutical Science College, Huai'an, Jiangsu 223003, China.
- School of Pharmacy, Jiangsu Food & Pharmaceutical Science College, Huai'an, Jiangsu 223003, China. Electronic address: 562250614@qq.com.
Zitieren
APA
Cheng, Z., Qian, T., Yu, J., Yan, Y., Jing, L., Yang, B., Tang, H., Yan, A., Liu, M., Song, Y., & Dai, J. (2025). The niacin receptor HCAR2 prevents sleep deprivation-induced cognitive impairment by inhibiting microglia-mediated neuroinflammation in mice. International Immunopharmacology, 162, 115174. https://doi.org/10.1016/j.intimp.2025.115174
Vancouver
Cheng Z, Qian T, Yu J, Yan Y, Jing L, Yang B, et al. The niacin receptor HCAR2 prevents sleep deprivation-induced cognitive impairment by inhibiting microglia-mediated neuroinflammation in mice. International Immunopharmacology. 2025;162:115174. doi:10.1016/j.intimp.2025.115174
BibTeX
@article{Cheng2025,
author = {Cheng, Zhaoyan and Qian, Tengda and Yu, Jiaqi and Yan, Yuhui and Jing, Lijia and Yang, Baowei and Tang, Huiling and Yan, Aiwen and Liu, Mengqi and Song, Yuewen and Dai, Jing},
title = {The niacin receptor HCAR2 prevents sleep deprivation-induced cognitive impairment by inhibiting microglia-mediated neuroinflammation in mice},
journal = {International Immunopharmacology},
year = {2025},
volume = {162},
pages = {115174},
doi = {10.1016/j.intimp.2025.115174}
}
EUVIMED